Study of Alemtuzumab Versus Anti-Thymocyte Globulin to Help Prevent Rejection in Kidney and Pancreas Transplantation

This study is currently recruiting participants.

Study NCT00331162 Information provided by Wake Forest University Baptist Medical Center

First Received: May 26, 2006 Last Updated: December 3, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	June 2015
Estimated Primary Completion Date:	June 2014 (Final data collection date for primary outcome measure)